Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-004648
Filing Date
2025-04-10
Accepted
2025-04-10 07:36:04
Documents
120
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 20-F rdhl-20241231x20f.htm   iXBRL 20-F 3408145
2 EX-2.3 rdhl-20241231xex2d3.htm EX-2.3 86615
3 EX-4.10 rdhl-20241231xex4d10.htm EX-4.10 98150
4 EX-11.1 rdhl-20241231xex11d1.htm EX-11.1 40269
5 EX-12.1 rdhl-20241231xex12d1.htm EX-12.1 13315
6 EX-12.2 rdhl-20241231xex12d2.htm EX-12.2 16149
7 EX-13 rdhl-20241231xex13.htm EX-13 9658
8 EX-15.1 rdhl-20241231xex15d1.htm EX-15.1 5225
9 GRAPHIC rdhl-20241231x20f008.jpg GRAPHIC 3984
10 GRAPHIC rdhl-20241231xex15d1001.jpg GRAPHIC 3033
  Complete submission text file 0001558370-25-004648.txt   11768396

Data Files

Seq Description Document Type Size
11 EX-101.SCH rdhl-20241231.xsd EX-101.SCH 101815
12 EX-101.CAL rdhl-20241231_cal.xml EX-101.CAL 60834
13 EX-101.DEF rdhl-20241231_def.xml EX-101.DEF 286755
14 EX-101.LAB rdhl-20241231_lab.xml EX-101.LAB 622532
15 EX-101.PRE rdhl-20241231_pre.xml EX-101.PRE 484544
123 EXTRACTED XBRL INSTANCE DOCUMENT rdhl-20241231x20f_htm.xml XML 1954977
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 20-F | Act: 34 | File No.: 001-35773 | Film No.: 25826506
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)